Irritable Bowel Syndrome John McLaughlin Clinical Lecturer/Consultant Gastroenterologist Hope Hospital, Salford.

Slides:



Advertisements
Similar presentations
Diagnostic Work-up. There is no specific laboratory or imaging test to diagnose irritable bowel syndrome. Currently the diagnosis of IBS relies on meeting.
Advertisements

Irritable bowel syndrome in adults
Irritable Bowel Syndrome Dr Bruce Davies Sept 2001Bruce Davies2 Introduction First described in % of patients present
Audit of Impact of NICE guidelines for Ovarian Cancer Helen Losty Royal United Hospital Bath 17th November 2011.
Recurrent Abdominal Pain In Childhood and Adolescence
Irritable Bowel Syndrome
IBS or IBD: a N.I.C.E. Way to Tell
Overview of Irritable Bowel Syndrome
Bowels Behaving Badly BAHSHE Conference
Gastroenterological Pathology. History Nature & course of abdominal symptoms Associated s/s Past medical, family & surgical Hx Medications Could you be.
IRRITABLE BOWEL SYNDROME (IBS)
Irritable Bowel Syndrome Sam Thomson 3 rd November 2010.
Fibromyalgia. Fibromyalgia What do you know about fibromyalgia? What do you know about fibromyalgia? Who gets it? Who gets it? What is the cause? What.
Management of irritable bowel syndrome (IBS) WORKSHOP Dimitris Karanasios.
Irritable Bowel Syndrome
Irritable Bowel Syndrome Rahul Gladwin, MS3 University of Health Sciences Antigua School of Medicine rahul[AT]rahulgladwin.com.
Ian Arnott Consultant Gastroenterologist Western General Hospital Edinburgh The Use of Faecal Calprotectin in Primary Care.
Irritable Bowel Syndrome Biol E-163 TA session 12/18/06.
Irritable bowel syndrome in adults NICE Clinical Guideline 61 – February 2008.
IBS In The Elderly Monica J. Cox ARNP-BC, MSN, MPH Geriatric Nurse Practitioner G.I. Nurse Practitioner Borland-Groover Clinic Jacksonville, Florida.
Dr. Abdulrahman Aljebreen.  To know the ◦ pathophysiology, ◦ clinical features and ◦ how to diagnose and ◦ How to manage patients with IBS.
Irritable Bowel Syndrome 1481 Nadeem Khan March 2, 2015.
The Nature of Disease.
Focus on Irritable Bowel Syndrome (IBS)
Chronic pain Sai Yan Au. Chronic Pain  Definition  Causes and mechanisms of chronic pain  Effects of chronic pain  Assessment and evaluation  Management.
IRRITABLE BOWEL SYNDROME
Constipation: treatment in primary care, when to refer and novel therapies.... Lee Dvorkin Consultant General, Colorectal & Laparoscopic Surgeon Spire.
Irritable Bowel Syndrome By: Rocco Paolino. Definition A combination of intermittent abdominal pain, constipation and/or diarrhea.
Causes of Constipation. Main Point Constipation is a SYMPTOM Constipation is not a diagnosis.
1 Ellora Islam Jodie Ly Tony Davi Sonaiya Kelley.
1 Lotronex Postmarketing Experience Ann Corken Mackey, R.Ph., M.P.H. Allen Brinker, M.D., M.S. Zili Li, M.D., M.P.H., formerly of ODS Office of Drug Safety.
CHAPTER 21: The Psychology of Irritable Bowel Syndrome.
1- Irritable Bowel Syndrome (IBS) 2- Constipation
Irritable Bowel Syndrome. A functional bowel disorder characterized by abdominal pain or discomfort and altered bowel habits in the absence of detectable.
1. What is the most common cause of constipation? A.Pelvic floor dyssynergia B.Slow transit C.Functional D.Mechanical obstruction.
Management of Irritable Bowel Syndrome (IBS) in Family Medicine Meera Kaur, PhD, RD, CDE Assistant Professor, Family Medicine University of Manitoba, Canada.
Habit disorders Dr. Ibrahim Khasraw Lecturer in Pediatrics School of Medicine Sulaimani University of.
Are patients with chronic diseases a new challenge to general practice? Patients with irritable bowel syndrome in general practice Patients with irritable.
Definition Signs & symptoms Treatment Root of the disease.
FUNCTIONAL DYSPEPSIA H Ali Djumhana.
CLINICAL TIPS AND PEARLS. Clinical Tips and Pearls The most common type of chest pain is from myocardial infarction. The most common type of abdominal.
Anita R. Webb, PhD JPS Health Network Fort Worth, TX.
Changes in bowel movement-IBS Mohammed Alwahibi Khalid Alsadhan Walid Alkhamis.
IBS (Irritable Bowel Syndrome)
CANCER.
POLYPS CHOLORECTAL CANCER M. DuBois Fennal, PhD, RN, CNS.
Shad Johnson MPAS, PA-C Southeast Idaho Gastroenterology.
Irritable Bowel Syndrome
1- Irritable Bowel Syndrome (IBS) 2- Constipation
DYSPEPSIA Dr.Azam teimouri Gastroenterologist
Colorectal Cancer: Risk Prevention and Diagnosis
Changes in bowel movements (IBS)
IRRITABLE BOWEL SYNDROME
Focus on Irritable Bowel Syndrome (IBS)
Irritable bowel syndrome
Presenting with IBS symptoms, baseline assessment.
Irritable Bowel Syndrome (IBS)
IRRITABLE BOWEL SYNDROME
CHANGES IN BOWEL MOVMENTS (IBS)
Pathophysiology of Irritable Bowel Syndrome
Drugs for the treatment of irritable bowel syndrome (IBS)
Common Functional Gastroenterological Disorders Associated With Abdominal Pain  Adil E. Bharucha, MBBS, MD, Subhankar Chakraborty, MBBS, PhD, Christopher.
IRRITABLE BOWEL SYNDROME
Dr Rob Palmer – CCG Gastro Lead
Clinical tips and pearls
Volume 138, Issue 5, Pages (May 2010)
Management of Constipation in Adults
Human Digestive System
Irritable Bowel Syndrome (IBS)
Fibromyalgia.
Presentation transcript:

Irritable Bowel Syndrome John McLaughlin Clinical Lecturer/Consultant Gastroenterologist Hope Hospital, Salford.

IBS What is (are?) IBS? Symptoms and diagnosis Aetiology Therapy and management

What is IBS? IBS is NOT a disease IBS is NOT a singular pathological entity IBS cannot have a single aetiology –but IBS is a useful term, coined to group patients with similar, medically unexplained symptoms IBS is difficult to manage, particularly pharmacologically

IBS: features IBS patients have symptoms characterised by –Unexplained abdominal pain –Disturbed bowel habit –Bloating No ‘red flags’: bleeding, weight loss, abdominal masses, malnutrition etc Clinical diagnosis here VERY SAFE <40-50 yrs By definition, conventional investigations are normal: colonoscopy, histology, blood tests, radiology

Current Diagnostic Criteria: Rome II 1999 At least 12 weeks or more (in last year) of abdominal pain or discomfort with 2 out of 3 of the following: –Relieved by defaecation –Associated with change in stool frequency >3/day or <3/week –Associated with change in stool form Also supported by passage of mucus, bloating, straining, urgency, sense of incomplete evacuation

Problems with Rome II PATIENT A Abdominal pain Urgent loose stool 3-4 times each morning Sense of incomplete evacuation PATIENT B Abdominal pain Strains to pass pellety stool every 3-4 days Bloating++ Can these very different patients really have the same disorder or common pathophysiology?

‘Diarrhoea-predominant’ IBS –But when stools collected mean stool weight= 150g/day in ‘severe diarrhoea’ group –Diarrhoea is strictly >300g/day –More accurate to define as increased defaecatory frequency

NO! Seek and you shall find: –Functional Dyspepsia –Chronic Fatigue –Unexplained muscle pain (Fibromyalgia) –Temporomandibular dysfunction –Bladder symptoms –Gynaecological symptoms –Headaches –Backache –(All these body areas are normal too when investigated) Are symptoms confined to the bowel in IBS patients?

IBS symptoms are common 3-30% prevalence in unselected subjects 5% of all visits to GPs 25% of all visits to gastroenterologists Estimated 1% annual incidence No mortality from the disorder itself cf mortality from drugs, investigations, surgical procedures

IBS symptoms are common 3-30% prevalence in unselected subjects 5% of all visits to GPs 25% of all visits to gastroenterologists Estimated 1% annual incidence No mortality from the disorder itself cf mortality from drugs, investigations, procedures

Alosetron: 5-HT 3 antagonist (GSK) Approved February 9, 2000, and voluntarily withdrawn from the market November 28, Women with diarrhoea-predominant IBS. By November 10, 2000, FDA had reviewed 70 cases of serious post-marketing adverse events –49 cases of ischaemic colitis –21 cases of severe constipation. –Of the 70 cases, 34 resulted in hospitalization without surgery, 10 resulted in surgical procedures, and three resulted in death. In some cases alosetron produced constipation serious enough to require surgery. ?1: risk of ischaemic colitis. Put back on the market June 7, 2002 with stricter criteria, patient-doctor agreement

Aetiology of FGD Aetiology of FGID ? Gut Hypersensitivity ? Gut Hypersensitivity ? Abnormal processing ? Abnormal processing Spinal Cord ? Hypervigilance ( ( ) ) Central Sensitisation ?motility disorder

Altered Motility?- probably not Evidence is inconsistent: maybe just epiphenomena of invasive study methods Stress induces colonic contractility in IBS and control subjects ‘Diarrhoea’-predominant –Prominent motility response to feeding –Some reports of accelerated transit and fast propagation of colonic contractions Constipation-predominant –Some reports of reduced propagation of colonic contractions

Where is the Problem ? ? ? Hypersensitive Gut ? Hypervigilant CNS?

Functional gut disorders ‘VISCERAL HYPERSENSITIVITY’ –Low thresholds to gut pain (eg inflating balloons in rectum, pain with lower volumes in ballon) –Perhaps reflects previous injury? Inflammation, infection, nerve fibre injury (TAH) –akin to secondary hyperalgesia eg after burns –However, problem may still lie in central connections: why the associated disorders if due to gut injury??

Post-infectious IBS Post Campylobacter best reported (Spiller) Persistent neuroimmune dysfunction Persistent subtle inflammation –eg mast cell infiltration; increased permeability Enteroendocrine cell hyperplasia –eg rectal 5-HT cells in rectum –Increased circulating 5-HT reported in females ……‘IBS’ common in ‘IBD’

Where is the Problem ? ? ? Hypersensitive Gut ? Hypervigilant CNS?

Hypervigilance Can alter sensory thresholds by focussing attention on any body area If in pain, convinced something’s wrong, subject will focus attention there Vicious circle of increasing symptoms could arise Anxiety/depression heightens this further

Prevalence of psychological problems Community IBS: no excess GP Hospital Cause of symptoms or driver to seek medical care? Psychological factors may worsen outcome –eg physical or sexual abuse reportedly

Relative risk of postinfectious IBS- both biological and psychological! Adverse life events in the previous year: x 2 Female sex: x 3.4 Hypochondriasis: x 2 All 3 factors: x 7 Bacterial factors : 1 in 10 of Campylobacter infected individuals developed post-infective IBS compared with just 1 out of 100 with Salmonella

‘Biopsychosocial model’ Likely that components from each of these dimensions contribute to aetiology of IBS …. and other functional gut disorders

Therapeutic approach to IBS Need a better understanding of precise causes in mechanistically defined patient subgroups, not just ROME compliant trials –Peripheral/central origins Symptom-based approach: non-drug –Behavioural, psychological, hypnotherapy –Diet, exclusion Symptom-based approach: drugs –NB 20-70% placebo responses –Placebo benefits last 12 months or more

Therapeutic approach to IBS Positive diagnosis, rather than just failure to find something else Reassurance, minimal investigation Explanation ‘problem with the wiring rather than the plumbing’

Evidence for Therapy in IBS Fibre –Relieves constipation but worsens bloating Loperamide: empirically helpful Antispasmodics/anticholinergics –No good evidence –But may safely provide the placebo benefit

Evidence for Therapy in IBS Tricyclic antidepressants –Superior to placebo in meta-analysis SSRIs –No definite benefit from trials 5-HT 3 antagonist (alosetron) –12-17% benefit in female D-IBS 5-HT 4 agonist (tegasorod) –5-15% benefit in female C-IBS These need trials vs simple Rx not just placebo!

Evolving Therapy in IBS Novel agents in development –Antihypersensitivity Peripheral opioid antagonists Substance P, NMDA –Central pathways Corticotrophin releasing hormone antagonists –Motility CCK antagonists –Inflammation Steroids unhelpful in PI-IBS –Probiotics….

Summary and prospects IBS will remain a major cause of morbidity until its constituent causes are better understood As it has a social and experiential component, pharmacotherapy will largely be adjunctive at best Naïve studies with agents affecting visceral sensitivity are the best hope at present